(c) Room conductor blockage (Atrioventricular Block, known as AVB) is a cardiac disorder, which means that there are obstacles in the heart room during the transmission of a telecommunications signal, which leads to irregular coordination of electrical activity between the heart room and the heart room. Such obstruction may lead to slower heart beats and even serious heart function problems. The following is a detailed description of the characteristics, symptoms, causes and treatments of the room’s barrier.
What’s room conductor block? The heart’s beating is driven by telecommunications. These signals are sent from the indentation of the upper part of the heart, which is passed through to the heart room, and directs a rhythmic constriction and constriction of the heart. The room is like a “power stop” for the transmission of telecommunications from the heart to the heart. When the signal transmission of the room closes is blocked, the room transmission is blocked. Based on the severity of the retardation, the disease is divided into the following three types: the I room conductive retardation; the telecommunications transmission slows, but can still be transmitted to the heart. Often there are no symptoms, nor do they affect heart function. Room 2 transmission block: Some of the telecommunications were not delivered to the heart room and the heartbeat was missed. There are two types: Moe I (Vencil phenomenon): the signal is gradually delayed until it is completely blocked. Morse II: The signal is suddenly untransmittable, in the form of an intermittent leak. Room III transmission barrier (complete room block): The telecommunications number is completely unable to pass through the room, and the heart room and the heart room are beating independently. It is the most serious form that can lead to a slow or sudden death of the heart.
Symptoms of blockage of room transfer Symptoms of blockage of room transfer vary according to the type and severity of blockage: room blockage of room I is usually non-symptomatic and may be found only in an electrocardiogram. Second degree room block: light symptoms: heart attack, fatigue. In serious cases: dizziness, lack of strength, even fainting. · Distinct symptoms: severe heart attack, slow heart rate (less than 40 per minute). Dizziness, loss of consciousness, chest pain, short breath. This situation may endanger life and requires urgent treatment.
(b) Heart disease: Concertary heart disease: Inadequate heart blood supply can affect room closure. Cardiac inflammation: Cardiac inflammation may damage teletransmission. Myocardial infarction: cardiac damage leads to room transfer disorder. Cardiomy disease: e.g., amphibious or fat cardiac disease. (b) Demobilization of old age: As age increases, the functioning of the house is likely to deteriorate, leading to stagnation. Drug effects: Some drugs (e.g. beta receptor retardants, calcium route retardants or geo-sinks) may slow down the heart rate and cause or exacerbate room transfer retardation. Electrolytic disorders: Anomalous levels of potassium, calcium and magnesium in the body may interfere with heart electrical activity. Genetic diseases: Some family heart diseases increase the risk of room-to-room transmission retardation. Other factors: Post-operative complications. (b) Trauma, infection or inflammation.
(b) The EKG is a gold standard for the CTL, which clearly shows the transmission of the telecommunications. Different types of retardation may have different characteristics on the EKG. Dynamic electrocardiogram (Holter monitoring): A long record of cardiac electrical activity used to capture intermittent room retardation. Check if there’s an abnormal heart structure. Electrophysiological examination: In complex cases, room closure is assessed through electrophysiological tests.
The method of treating room-based room-based blockage depends on the type of blockage, its severity and the symptoms of the patient. I-room blockage: Usually treatment is not required and only regular observation is required. Avoid incentives (e.g., reduction of drug use, correction of electrolyte disorders). Room block II: Moe I: In minor cases, no treatment is required, but if symptoms are apparent, further assessment is required. Morse II: Cardiac pacemaker is usually required. Room III blockage: This is the most serious case and urgent treatment is required. The permanent pacemaker is the primary treatment used to maintain the normal beating of the heart. Temporary start-up or drug support (e.g., atropine) may be required in acute cases.
The pacemaker is the “life saver” for the medium-heavy room, especially room III. Its function is to maintain the heart rate: the pacemaker sends a telecommunications signal when the room closes are not able to conduct the signal properly, so that the heart room moves at the normal rhythm. Prevention of fainting and sudden death: prevent disruption of blood circulation by stabilizing the heartbeat. Modern pacemakers are small and functional, and patients are able to re-establish most of their daily activities after implantation.
(b) Control of heart disease; Reasonable use of drugs: Avoiding abuse of drugs that may affect heart rate and adjusting dosages in accordance with medical instructions. A healthy lifestyle: Stop smoking, keep a healthy diet and exercise. Periodic medical check-ups: cardiac check-ups should be conducted regularly, especially for the elderly and for groups with a history of heart disease.
In conclusion, room transfer retardation is a cardiac disorder, ranging from a slight I to a severe III blockage, with increasing symptoms and risks. Most I blockages do not require special treatment, while II and III blockages may require medical interventions such as pacemakers. Through early detection, scientific treatment and health management, most of the patients with room transfer barriers can lead normal lives. If you or anyone around you have heart-related symptoms, timely medical treatment is the most important guarantee! Let’s focus on the heart’s health and keep the engine of life safe.
Room traffic’s blocked.
